IMMUNOCORE HOLDINGS PLC (IMCR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$36.13-3.83%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · IMCR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 430.8 | 400.0 | 310.2 | 249.4 | 174.4 | 36.5 | — |
| Total Revenues | — | — | — | 249.4 | 174.4 | 36.5 | — |
| Cost of Revenues | 4.7 | 5.1 | 2.7 | 1.0 | 1.1 | 0.0 | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 164.2 | 165.4 | 155.8 | 144.5 | 123.1 | 110.8 | — |
| R&D Expenses | 284.5 | 274.9 | 222.2 | 163.5 | 101.9 | 100.2 | — |
| Operating Income | (22.6) | (45.4) | (70.5) | (59.6) | (51.7) | (174.6) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 12.2 | 18.8 | 5.2 | 5.4 | 5.6 | — |
| Interest & Investment Income | 15.0 | 16.5 | 25.6 | 18.0 | 3.8 | 0.1 | — |
| Net Interest Expenses | — | — | — | (12.8) | 1.7 | 5.5 | — |
| EBT, Incl. Unusual Items | (2.7) | (19.1) | (52.9) | (60.9) | (40.9) | (179.9) | — |
| Income Tax Expense | 15.3 | 16.4 | (1.9) | (5.6) | 11.7 | 0.2 | — |
| Net Income | |||||||
| Net Income | (18.1) | (35.5) | (51.1) | (55.3) | (52.5) | (180.0) | — |
| Per Share | |||||||
| Basic EPS | (0.35) | (0.71) | (1.02) | (1.13) | (1.15) | (4.24) | — |
| Diluted EPS | (0.35) | (0.71) | (1.02) | (1.13) | (1.15) | (4.24) | — |
| Revenue per Share | 8.45 | — | — | — | — | — | — |
| Dividend per Share | — | — | — | 0.00 | 0.00 | — | — |
| Basic Weighted Avg Shares | 51.0 | 50.3 | 50.0 | 48.9 | 45.7 | 42.5 | — |
| Diluted Weighted Avg Shares | 51.0 | 50.3 | 50.0 | 48.9 | 45.7 | 42.5 | — |
| Supplemental | |||||||
| EBITDA | — | (42.3) | (66.3) | (55.5) | (46.4) | (167.0) | — |
| EBIT | (22.6) | (45.4) | (70.5) | (59.6) | (51.7) | (174.6) | — |
| Effective Tax Rate | -561.6% | — | — | 9.2% | -28.5% | -0.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.